{
    "clinical_study": {
        "@rank": "102682", 
        "arm_group": [
            {
                "arm_group_label": "Dose 1 of DRM04B", 
                "arm_group_type": "Experimental", 
                "description": "DRM04B"
            }, 
            {
                "arm_group_label": "Dose 2 of DRM04B", 
                "arm_group_type": "Experimental", 
                "description": "DRM04B"
            }, 
            {
                "arm_group_label": "Dose 1 of DRM04", 
                "arm_group_type": "Active Comparator", 
                "description": "DRM04"
            }, 
            {
                "arm_group_label": "Dose 2 of DRM04", 
                "arm_group_type": "Active Comparator", 
                "description": "DRM04"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vehicle"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess the safety of 2 doses of DRM04B compared to 2 doses of\n      DRM04 and vehicle (5 treatment arms) for the treatment of axillary hyperhidrosis when\n      applied once daily for 4 weeks followed by a 2-week post-dose period."
        }, 
        "brief_title": "Comparator Study of the Effect of DRM04B and DRM 04 in Subjects With Axillary Hyperhidrosis", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperhidrosis", 
        "condition_browse": {
            "mesh_term": "Hyperhidrosis"
        }, 
        "detailed_description": {
            "textblock": "This is a  randomized, double-blind, vehicle controlled, parallel group, comparator study\n      designed to assess the safety, efficacy and pharmacokinetics of two doses of DRM04B compared\n      to two doses of DRM04 compared to vehicle, 5 treatment arms.\n\n      Efficacy will be assessed through gravimetric assessment of sweat production using Patient\n      Reported Outcome and the Hyperhidrosis Disease Severity Score (HDSS).\n\n      Safety will be assessed through adverse events, local skin responses, serum chemistry and\n      hematology laboratory testing, ECGs, physical examination and vital signs.\n\n      PK blood samples will be taken study subjects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, 18 years of age or older.\n\n          -  Primary, axillary hyperhidrosis of at least 6 months duration.\n\n          -  Hyperhidrosis Disease Severity Score (HDSS) of 3 or 4 at baseline.\n\n          -  For each axilla, a baseline gravimetric measurement of sweat production of at least\n             50 mg over 5 minutes, while at rest, at room temperature.\n\n          -  Male or non-pregnant, non-lactating females.\n\n        Exclusion Criteria:\n\n          -  Current pregnancy or lactation.\n\n          -  Prior surgical procedure for hyperhidrosis.\n\n          -  Any prior axillary treatment with an anti-hyperhidrosis medical device\n\n          -  Interventional investigational product in the past 6 months prior to\n             Baseline/Day 1.\n\n          -  Prior treatment with botulinum toxin (e.g., Botox\u00ae) for axillary hyperhidrosis within\n             1 year of Baseline/Day 1.\n\n          -  Subjects with clinically significant abnormalities in laboratory values.\n\n          -  Subjects with a positive Hepatitis or HIV.Hepatitis B surface antibody positive is\n             allowed only if the subject has a history of having received Hepatitis B vaccination\n             and there are no clinically significant abnormalities in screening liver function\n             tests.\n\n          -  Treatment with cholinergic, serotonergic antagonists, and dopamine partial agonists\n             thought to relieve antidepressant-induced hyperhidrosis, within one month prior to\n             Baseline/Day 1.\n\n          -  Treatment with psychotherapeutic medications for less than 4 months prior to\n             Baseline/Day 1.\n\n          -  Treatment with topical or systemic anticholinergics, adrenergic agonists (clonidine),\n             or beta-blockers within 4 weeks of the baseline visit\n\n          -  Prior treatment with axillary iontophoresis within 4 weeks of Baseline/Day 1.\n\n          -  Any previous IV or oral treatment with the study drug.\n\n          -  Prior treatment with the topical study drug in a previous trial.\n\n          -  Axillary use of nonprescription or prescription antiperspirants within 2 weeks of\n             study enrollment.\n\n          -  Presence of a condition, within 10 years of enrollment, that may cause secondary\n             hyperhidrosis\n\n          -  Menopausal women who have had symptoms of menopause such as sweating or flushing\n             within 3 years of the study may not be enrolled.\n\n          -  Known history of Sj\u00f6gren's syndrome or Sicca syndrome.\n\n          -  History of glaucoma, inflammatory bowel disease, toxic megacolon, or febrile illness.\n\n          -  Men with a history of urinary retention requiring catheterization due to prostatic\n             hypertrophy or severe obstructive symptoms of prostatic hypertrophy.\n\n          -  Abnormal findings on screening ECG deemed clinically significant by the Investigator.\n\n          -  History or presence of ventricular arrhythmias, atrial fibrillation, atrial flutter.\n             History of other supraventricular tachycardia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129660", 
            "org_study_id": "DRM04-HH02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dose 1 of DRM04B", 
                "description": "Not provided", 
                "intervention_name": "Dose 1 of DRM04B", 
                "intervention_type": "Drug", 
                "other_name": "Not provided"
            }, 
            {
                "arm_group_label": "Dose 2 of DRM04B", 
                "description": "Not provided", 
                "intervention_name": "Dose 2 of DRM04B", 
                "intervention_type": "Drug", 
                "other_name": "Not provided"
            }, 
            {
                "arm_group_label": "Dose 1 of DRM04", 
                "description": "Not provided", 
                "intervention_name": "Dose 1 of DRM04", 
                "intervention_type": "Drug", 
                "other_name": "Not provided"
            }, 
            {
                "arm_group_label": "Dose 2 of DRM04", 
                "description": "Not provided", 
                "intervention_name": "Dose 2 of DRM04", 
                "intervention_type": "Drug", 
                "other_name": "Not provided"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "description": "Not provided", 
                "intervention_name": "Vehicle", 
                "intervention_type": "Other", 
                "other_name": "Not provided"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 20, 2014", 
        "location": [
            {
                "contact": {
                    "email": "amessina@cdcrinstitute.com", 
                    "last_name": "Alisa Messina, RN", 
                    "phone": "760-203-3839", 
                    "phone_ext": "103"
                }, 
                "facility": {
                    "address": {
                        "city": "Encinitas", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92024"
                    }, 
                    "name": "California Dermatology & Clinical Research Institute"
                }, 
                "investigator": {
                    "last_name": "Stacy R Smith, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "galynac@centerforderm.com", 
                    "last_name": "Galyna Cavallaro, CRC", 
                    "phone": "510-797-0110"
                }, 
                "facility": {
                    "address": {
                        "city": "Fremont", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94538"
                    }, 
                    "name": "Center For Dermatology Clinical Research"
                }, 
                "investigator": {
                    "last_name": "Sunil S. Dhawan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33609"
                    }, 
                    "name": "Olympian Clinical Research"
                }, 
                "investigator": {
                    "last_name": "Matthew Zook, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carmel", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46032"
                    }, 
                    "name": "Shideler Clinical Research Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "krakes@haberderm.com", 
                    "last_name": "Karen Rakes", 
                    "phone": "216-932-5200"
                }, 
                "facility": {
                    "address": {
                        "city": "Beachwood", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44122"
                    }, 
                    "name": "Haber Dermatology and Cosmetic Surgery"
                }, 
                "investigator": {
                    "last_name": "Robert Haber, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }, 
                    "name": "Virginia Clinical Research, Inc."
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "ckoliha@daseattle.com", 
                    "last_name": "Catherine Koliha, RN", 
                    "phone": "206-267-2100"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98101"
                    }, 
                    "name": "Dermatology Associates"
                }, 
                "investigator": {
                    "last_name": "Peter J Jenkin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mlee@seattlewomens.com", 
                    "last_name": "Mary Beth Lee, CCRC", 
                    "phone": "206-522-3330", 
                    "phone_ext": "111"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }, 
                    "name": "Women's Clinical Research Center"
                }, 
                "investigator": {
                    "last_name": "Robin Kroll, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Lpea@olympianresearch.com", 
                    "last_name": "DeAnn Dickinson, BS, RN, CCRS", 
                    "phone": "813-849-5566"
                }, 
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99204"
                    }, 
                    "name": "Premier Clinical Research"
                }, 
                "investigator": {
                    "last_name": "William P Werschler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vbarbin@innovaderm.ca", 
                    "last_name": "Val\u00e9rie Barbin", 
                    "phone": "514-521-3111", 
                    "phone_ext": "x214"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "zip": "H2K 4L5"
                    }, 
                    "name": "Innovaderm Research Inc."
                }, 
                "investigator": {
                    "last_name": "Catherine Maari, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "5", 
        "official_title": "A Phase 2, Randomized, Double-Blind Vehicle-Controlled Comparator Study of the Effect of DRM04B and DRM04 in Subjects With Axillary Hyperhidrosis", 
        "other_outcome": [
            {
                "description": "Not provided", 
                "measure": "Patient Reported Outcome absolute change in the questions from Baseline to Week 4", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "Not provided", 
                "measure": "Patient Reported Outcome change in the questions from Baseline to Week 6", 
                "safety_issue": "No", 
                "time_frame": "Week 6"
            }, 
            {
                "description": "Not provided", 
                "measure": "Patient Reported Outcome Shift tables comparing Baseline to Week 4 and Week 6 for each treatment group", 
                "safety_issue": "No", 
                "time_frame": "Week 6"
            }, 
            {
                "description": "Not provided", 
                "measure": "Patient Reported Outcome change in the question 6 from Baseline to Week 4 and Week 6", 
                "safety_issue": "No", 
                "time_frame": "Week  6"
            }, 
            {
                "description": "Not provided", 
                "measure": "Patient Reported Outcome exploratory PK/PD relationships will be assessed", 
                "safety_issue": "No", 
                "time_frame": "Week 6"
            }
        ], 
        "overall_contact": {
            "email": "ereed@tklresearch.com", 
            "last_name": "Emilie Reed", 
            "phone": "201-587-0500", 
            "phone_ext": "3362"
        }, 
        "overall_contact_backup": {
            "email": "lynne@dermira.com", 
            "last_name": "Lynne M Deans, MT", 
            "phone": "650-421-7484"
        }, 
        "overall_official": {
            "affiliation": "Dermira, Inc.", 
            "last_name": "Lynne M. Deans, MT", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Not provided", 
                "measure": "Proportion of subjects who have a minimum 1-grade improvement in HDSS from Baseline at Week 4", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "Not provided", 
                "measure": "Proportion of subjects who have a minimum 2-grade improvement in HDSS from Baseline at Week 4", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "Not provided", 
                "measure": "Absolute change in the gravimetrically measured sweat production from Baseline to Week 4", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "Not provided", 
                "measure": "Absolute change in the gravimetrically measured sweat production from Baseline to Week 6", 
                "safety_issue": "No", 
                "time_frame": "Week 6"
            }, 
            {
                "description": "Not provided", 
                "measure": "Proportion of subjects who have a minimum 1-grade improvement in HDSS from Baseline at Week 6", 
                "safety_issue": "No", 
                "time_frame": "Week 6"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129660"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Dermira, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dermira, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}